Tennessee ophthalmologists dispute legislation allowing ODs to use injectable anesthesia

Article

The Tennessee Academy of Ophthalmology (TNAO) is opposing a recently filed bill (SB220/HB555) that, as amended, would allow optometrists to inject local anesthesia into the tissue surrounding the eye in order to perform surgery.

Nashville, TN-The Tennessee Academy of Ophthalmology (TNAO) is opposing a recently filed bill (SB220/HB555) that, as amended, would allow optometrists to inject local anesthesia into the tissue surrounding the eye in order to perform surgery.

The legislation would expand optometrists’ scope of practice to allow them to inject anesthesia into the tissues surrounding the eyelid. Under the legislation, optometrists would be permitted to perform more advanced surgical procedures that require an injectable anesthetic.

“This legislation would create an unnecessary risk to patients and is a threat to the quality of surgical care in Tennessee,” said Ben Mahan, MD, president of the TNAO. “Anytime a needle is placed near the eye, there are serious risks to the patient that require clinical experience and expert judgment. A surgical error of just a few millimeters can result in a punctured eyeball and catastrophic vision loss.

“Whether it is injections to prepare for surgery or the surgery itself, patients have a right to know that the individual performing the procedure is a qualified medical doctor and surgeon,” Dr. Mahan said.

See the upcoming April issue of Optometry Times for deeper coverage on the Tennesee bill.

Read the original story

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.